Factor V Leiden mutation: a contributory factor for cerebral palsy?

Area of Science:

• Pediatric Neurology
• Genetics
• Thrombophilia

Background:

• Cerebral palsy (CP) is a common childhood neurological disorder.
• Vascular thrombosis is a potential complication in children with CP.
• The factor V Leiden (fVL) mutation is a known genetic risk factor for thrombophilia.

Purpose of the Study:

• To investigate the association between the factor V Leiden (fVL) mutation and vascular thrombosis in children with cerebral palsy (CP).
• To compare the frequency of the fVL mutation in children with CP and thrombosis versus those with CP and other findings.

Main Methods:

• Case-control study involving children with CP and vascular thrombosis (study group) and children with CP and other imaging findings (control group).
• Genetic testing for the factor V Leiden (fVL) mutation using blood spots or buccal swabs.
• Maternal interviews for antenatal, perinatal, demographic, and socio-economic data collection.

Main Results:

• The frequency of the fVL mutation was not statistically different between the study group (10.5%) and the control group (32% had spastic hemiplegia).
• The fVL mutation frequency was significantly higher than the expected population frequency (4%) in the study group (10.5%, p=0.012).
• The fVL mutation frequency was also significantly higher than the expected population frequency in mothers of the control group (7.2%, p=0.036).

Conclusions:

• The factor V Leiden mutation does not appear to be a significant risk factor specifically for vascular thrombosis in children with cerebral palsy.
• Elevated prevalence of the fVL mutation in both CP groups suggests a potential broader genetic predisposition in this population.
• Further research is needed to understand the complex interplay of genetic and environmental factors in CP and associated thrombotic events.